Effects of a SGLT2 Inhibitor in type 2 Diabetes Mellitus

Effects of a SGLT2 Inhibitor in type 2 Diabetes Mellitus - Effects of a SGLT2 Inhibitor in type 2 DM

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017461

Enrollment

Registered

2015-05-08

Start date

2014-06-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 Diabetes Mellitus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients are determined to be treated with a SGLT2 Inhibitor

Exclusion criteria

Exclusion criteria: The patient: *has a history of allergy to this drug *has moderate or severer kidney disease with uncontorolled electrolyte imbalance, volume overload, and/or advanced malnutrition *is on renal replacement therapy *has developed type1 DM *has diabetic ketoacidosis or diabetic -/pre comatose *is with severe infectious disease, in perioperative period, or with severe trauma *is under the twenty years of age *is unable to give a written informed concent

Design outcomes

Primary

Measure	Time frame
blood glucose body weight	—

Secondary

Measure	Time frame
renal function uremic toxin	—

Countries

Japan

Contacts

Public ContactKenji Koizumi

Tohoku University Hospital Nephrology, endocrinology and vascular medicine

kenjikoism@med.tohoku.ac.jp022-717-7163

Outcome results